We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 20 start-ups with an aggregate funding of $1.7b. The average funding per company in this subset is $86.5m.
Last update to the database: Feb 18, 2025. See changelog.
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
1
Funding Rounds
$225.0m
Money raised
A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.
9
Funding Rounds
$262.0m
Money raised
Semma Therapeutics is a biotechnology company making regenerative medicine therapies using stem cells.
2
Funding Rounds
$114.0m
Money raised
Aspen Neuroscience develops autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS disorders.
3
Funding Rounds
$224.0m
Money raised
Healios is a biotechnology company developing stem cell regenerative medicine therapies for the treatment of retinal and age-related macular diseases.
1
Funding Rounds
$9.9m
Money raised
Bone Therapeutics is a biotechnology company developing cell therapy treatments for orthopaedics and bone disease.
1
Funding Rounds
$10.4m
Money raised
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable.
3
Funding Rounds
$157.3m
Money raised
I Peace is a technology company that provides research and development services for GMP products, drug discovery, and personal iPSC banking.
3
Funding Rounds
$35.3m
Money raised
Shoreline Biosciences, Inc. is a Cell-Based Immunotherapies founded in 2020 by Kleanthis G. Xanthopoulos.
4
Funding Rounds
$229.0m
Money raised
Stemson Therapeutics is an iPSC Hair Loss Treatment founded by Geoff Hamilton.
2
Funding Rounds
$22.5m
Money raised
mRNA-based technology to develop engineered cell therapies for solid and liquid tumors
2
Funding Rounds
$6.0m
Money raised
Laverock Therapeutics is a skylark Therapeutics is now Laverock Therapeutics founded in 2022.
1
Funding Rounds
$16.0m
Money raised
Clade Therapeutics is a stem Cell Therapies founded by Jim Glasheen, Chad Cowan and Leandro Vetcher.
1
Funding Rounds
$87.0m
Money raised
Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure
2
Funding Rounds
$63.0m
Money raised
Vita Therapeutics is a company founded in 2018.
2
Funding Rounds
$44.0m
Money raised
Neurophth Therapeutics is an ophthalmology Gene Therapy.
2
Funding Rounds
$122.0m
Money raised
Notch Therapeutics is a gene-modified T cell therapy.
1
Funding Rounds
$85.0m
Money raised
Greenstone is a platform computational biology startup company at Stanford Research Park, located at Alexandria Center for Life Sciences.
1
Funding Rounds
$11.2m
Money raised
Developer of stem cell-based therapies for vision restoration.
1
Funding Rounds
$590.0k
Money raised
RYNE Biotechnology Inc. is an iPSC dopamine progenitor founded in 2022.
1
Funding Rounds
$5.0m
Money raised